Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xinjiang Tianyi Runze Bioengineering is a Chinese biotechnology company headquartered in Changji, Xinjiang, that specializes in the research, development, and manufacturing of veterinary biological products. The company is primarily recognized for its production of livestock vaccines, specifically those targeting Brucellosis, such as the Brucella Melitensis (Strain M5-90) live vaccine. Operating with GMP-certified facilities, it provides critical animal health solutions to support the livestock industry and regional biosecurity. In addition to vaccines, the company explores bio-feed additives and other bioengineering applications for agricultural use. It serves as a key supplier for national and regional animal disease prevention and control programs in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xinjiang Tianyi Runze Bioengineering.